FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Biogen (NASDAQ: BIIB) reported Q1 EPS of $4.79, $0.33 better than the analyst estimate of $4.46. Revenue for the quarter came in at $2.73 billion versus the consensus estimate of $2.75 billion.
Growth was driven by a 15% increase in worldwide TECFIDERA revenues as well as... More

